Healthcare Technologies (ADS)
Analytic Diabetic Systems (ADS)
ADS is a predictive analytics company with expertise in AI and machine learning applied to several core healthcare system needs. Founded by Aptima, Inc.’s commercialization arm, Aptima Ventures LLC, ADS is the creator of GlyCU which provides predictive glycemic control analytics and monitoring to save lives, reduce labor, and decrease costs in the ICU.
GlyCU Product Information
About Analytic Diabetic Systems (ADS)
ADS Team
- Dr. Scott M. Pappada, Co-Founder and Director, ADS
- Jeffrey Morrill, Business Development, ADS
- Dr. John Feeney, Principal Research Engineer, Aptima, Inc.
- William “Noah” DePriest, Senior Software Engineer, Aptima, Inc.
ADS Board of Directors
- Daniel Serfaty, President
- Dr. John Feeney, Secretary
- Margaret J. Clancy, Treasurer
- Dr. Scott M. Pappada
- Kevin Coppersmith
For more information, please contact Jeffrey Morrill at jmorrill@analyticdiabeticsystems.com.
